Free Republic

An outpatient study is reporting a combination of zinc, hydroxychloroquine, and azithromycin significantly reduces hospitalization and death for COVID-19 positive patients, cutting mortality rate to a mere 0.3%. The current COVID-19 positive case mortality rate is 5.26%, according to the study. Azithromycin is more commonly known as Z-Pak. The key note of this study, according to CrowdProtocol doctors, is the early treatment of COVID-19 in outpatients before they require hospitalization for a severe COVID-19 case, the latter of which was used to suggest no benefit to HCQ use in hospitalized patients. "What differentiates this study is that patients were...

Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744).

The antimalarial drug candidate for coronavirus has long been introduced as a 'game-changer' in treating COVID-19 patients. However, in recent studies, contrasting results have been seen in patients. Some claim to have improved their condition with the help of the drug, while others blame the cure for the adverse reactions it brings. A new study from New York suggests that the drug may yield better results when used in combination with the dietary supplement, zinc. Researchers from the NYU Grossman School of Medicine placed a medical preprint on their site on Monday. Their paper is yet to be peer-reviewed. In...

A Los Angeles doctor praised using hydroxychloroquine to treat COVID-19 during an interview with a local news station on Sunday, claiming that it has a dramatic effect on patients who are seriously ill when combined with zinc. Dr. Anthony Cardillo, CEO of Mend Urgent Care, made the remarks during an interview with ABC 7 news anchor Jory Rand. “What we’re finding clinically with our patients is that it really only works in conjunction with zinc. So the hydroxychloroquine opens the zinc channel, zinc goes into the cell, it then blocks the replication of the cellular machinery,” Cardillo said. “So, it...

We told you several weeks ago about the Orange County, New York doctor – Vladimir Zelenko – who has had tremendous success in treating hundreds of symptomatic coronavirus patients with a combination of hydroxycholoroquine and antibiotics. That course of medication is now being copied by many doctors around the country, despite the best efforts of Dr. Anthony Fauci and the corrupt news media to hide the crucial information from the public. This morning comes news out of Los Angeles of another doctor, Anthony Cardillo, who is experiencing similar success in treating his own patients. His approach is slightly different from...

Yet another positive report: LOS ANGELES -- A Los Angeles doctor said he is seeing significant success in prescribing the malaria drug hydroxychloroquine in combination with zinc to treat patients with severe symptoms of COVID-19. Hydroxychloroquine has been touted as a possible treatment for COVID-19 by President Trump among others, but it remains controversial as some experts believe it is unproven and may not be effective. The drug has long been used for treatment of malaria and conditions such as lupus and arthritis but is not technically approved by the FDA for COVID-19. The agency, however, is encouraging trials and...

I am hoping the President or one of his advisors reads stuff here... Please sir, meet with this doctor who is a board-certified family practitioner in New York. He has used his protocol on 900 so far with incredible results. Would you please meet with him to just have another voice you can weigh in the decisions you are making?

Over the past three weeks, we’ve been sharing with you the great work Dr. Zelenko, a board-certified family practitioner in New York, has been doing in the treatment of COVID-19 patients in New York. In our last piece, Dr. Vladimir Zelenko treated 700 coronavirus patients treated with 99.9% success rate using Hydroxychloroquine, 1 outpatient died after not following protocol.

Patrick Rooney of Old School™ comments following the White House Coronavirus news briefing Sunday evening, March 29, 2019. The President extended "social distancing" guidelines until April 30th based on recommendations from his medical advisers Dr. Anthony Fauci and Dr. Deborah Birx. At the briefing, Dr. Fauci repeated this concern that 100-200,000 Americans could die from Coronavirus (COVID-19) if steps are not taken to prevent this. The President stated that the anti-malaria drug Hydrochloroquine is being tested in New York state, and that 1,100 are in a study. Governor Andrew Cuomo has given a directive that people outside the study group...

Over the weekend, the Food and Drug Administration (FDA) issued an emergency authorization for the use of hydroxychloroquine (HCQ) and chloroquine (CQ) to treat hospitalized COVID-19 patients. Simultaneously, the Department of Health and Human Services (HHS) announced that Sandoz has donated 30 million doses of HCQ and Bayer one million doses of CQ to the Strategic National

Dr. Stephen Smith, founder of the Smith Center for Infectious Diseases and Urban Health in East Orange, New Jersey, said the remarkable results he is seeing in his coronavirus patients using a combination of the anti-malaria drug hydroxychloroquine and the antibiotic azithromycin marks the “beginning of the end” of the COVID-19 pandemic. Appearing on Fox News’ “The Ingraham Angle” on Wednesday night, Smith said not a single patient he has been treating with the combination over a five-day period has had to be placed on a ventilator.

An international poll of more than 6,000 doctors released Thursday found that the antimalarial drug hydroxychloroquine was the most highly rated treatment for the novel coronavirus. The survey conducted by Sermo, a global health care polling company, of 6,227 physicians in 30 countries found that 37% of those treating COVID-19 patients rated hydroxychloroquine as the “most effective therapy” from a list of 15 options. The U.S. Food and Drug Administration gave chloroquine and its next-generation derivative, hydroxychloroquine, emergency-use authorization Monday for treating the novel coronavirus, although the drug was already being used off-label by some doctors and hospitals for COVID-19...

Doctors who have treated a combined total of over 425 confirmed or presumptive Chinese coronavirus patients with the drug hydroxychloroquine told Breitbart News they are finding the medication to be helpful.

As of April 1, 1524 total patients have been treated with Hydroxychloroquine with Azithromycin. Of this population, only 1 death has been recorded.

rance has now officially sanctioned the malaria drug chloroquine as a potential coronavirus treatment for patients infected with the novel coronavirus. In the U.S. President Donald Trump has also been touting the use of chloroquine and a couple of other anti-malarial drugs to fight the deadly virus. "This ensures continued treatment of patients who have been treated for several years for a chronic condition with this drug but also allows a temporary authorization to allow certain patients with coronavirus to benefit from this therapeutic route," France 24 English quoted Jérôme Salomon, France's director-general of health. Also, the U.S.FDA has acted...

Early data from yet another study of the antimalaria drug hydroxychloroquine in Covid-19 patients is interesting, and perhaps promising, but doesn’t clear up questions about the therapy’s efficacy, analysts say. The study, conducted by scientists at the Renmin Hospital of Wuhan University and distributed before peer review on Monday, is among the first randomized, double-blind clinical trials of hydroxychloroquine in Covid-19 patients. The drug has received enormous attention as an experimental Covid-19 treatment after President Trump highlighted its perceived potential in media briefings and on Twitter, and the Food and Drug Administration authorized its use to treat Covid-19 on an...

First, let's talk a bit about zinc. It is an essential mineral for one's health. We cannot live without it. But we don’t need very much. About 15 mgs a day will do. Zinc is important in wound healing, the functioning of our immune system, eyesight, brain development, the proper functioning of sperm and the synthesis of testosterone. (The latter might explain the traditional belief that oysters possess aphrodisiac properties due to their high zinc content). Even our senses of smell and taste depend on enzymes that include zinc in their molecular structure. The possibility of zinc having antiviral activity...

On March 19, we published a story about a trial study conducted by French researchers which showed a combination of Hydroxychloroquine (plaquenil) and Azithromycin to be effective in the treatment of COVID-19 patients. The study, which was led by renowned Didier Raoult​ M.D/Ph.D, et. al in France, showed that 100% of patients that received a combination of the two anti-malaria drugs tested negative and were virologically cured within 6 days of treatment. The first preliminary trial involved a total of 36 COVID-19 patients. However, U.S. health agencies like FDA and CDA, are still very cautious about the effectiveness and safety...

The push in the U.S. pandemic epicenter follows the president’s declaration that he ‘feels good’ about compounds with unproven efficacy, hydroxychloroquine and chloroquine. New York is moving at unprecedented speed and scale in a human experiment to distribute tens of thousands of doses of anti-malarial drugs to seriously ill patients, spurred by political leaders including President Trump to try a treatment that is not proved to be effective against the coronavirus. With no proven treatment for the coronavirus, and infections in New York topping 30,000, health experts say the Food and Drug Administration has moved with uncommon speed to authorize...

Last Wednesday, we published the success story from Dr. Vladimir Zelenko, a board-certified family practitioner in New York, after he successfully treated 350 coronavirus patients with 100 percent success using a cocktail of drugs: hydroxychloroquine, in combination with azithromycin (Z-Pak), an antibiotic to treat secondary infections, and zinc sulfate. Now, Dr. Zelenko provides updates on the treatment after he successfully treated 699 COVID-19 patients in New York. In an exclusive interview with former New York Mayor, Rudy Giuliani, Dr. Vladmir Zelenko shares the results of his latest study, which showed that out of his 699 patients treated, zero patients died,...